Skip to main content
COSM
NASDAQ Life Sciences

宇宙健康的Liv18肝脏补充剂开始销售,预计年收入500万美元以上,毛利率为75%

feedReported by Access Newswire
Sentiment info
Positive
Importance info
9
Price
$0.378
Mkt Cap
$19.196M
52W Low
$0.28
52W High
$1.32
Market data snapshot near publication time

summarizeSummary

宇宙健康宣布其Liv18肝脏健康补充剂的第1阶段执行已成功完成,生产和销售于2026年4月开始。这一更新提供了关于美国启动的具体进展,而美国启动最初计划于2026年第二季度,于4月8日宣布。该公司预计Liv18将产生超过500万美元的年收入,毛利率约为75%,这相对于宇宙健康的当前市场估值是一项非常重要的财务贡献。这种加速的商业化和强劲的收入/利润率预测表明公司的美国扩张和整体盈利能力将获得显著提升。投资者将密切关注初期销售表现和这些财务目标的实现。

在该公告发布时,COSM的交易价格为$0.38,交易所为NASDAQ,所属行业为Life Sciences,市值约为$1919.6万。 52周交易区间为$0.28至$1.32。 这则新闻被评估为积极市场情绪,重要性评分为9/10。 来源:Access Newswire。


show_chartPrice Chart

Share this article

Copied!

feed COSM - Latest Insights

COSM
Apr 24, 2026, 4:30 PM EDT
Filing Type: S-3/A
Importance Score:
9
COSM
Apr 20, 2026, 10:55 AM EDT
Source: Access Newswire
Importance Score:
9
COSM
Apr 17, 2026, 2:00 PM EDT
Source: Access Newswire
Importance Score:
7
COSM
Apr 15, 2026, 4:34 PM EDT
Filing Type: 10-K
Importance Score:
9
COSM
Apr 15, 2026, 9:25 AM EDT
Source: Access Newswire
Importance Score:
9
COSM
Apr 13, 2026, 12:50 PM EDT
Source: Access Newswire
Importance Score:
7
COSM
Apr 10, 2026, 9:40 AM EDT
Source: Access Newswire
Importance Score:
9
COSM
Apr 08, 2026, 11:10 AM EDT
Source: Access Newswire
Importance Score:
8
COSM
Apr 01, 2026, 11:42 AM EDT
Source: Access Newswire
Importance Score:
7
COSM
Mar 19, 2026, 12:45 PM EDT
Source: GlobeNewswire
Importance Score:
9